These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28834736)
1. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP. Chen W; Wen Z; Zhang J; Li C; Huang K; Bu Z J Virol Methods; 2018 Feb; 252():1-7. PubMed ID: 28834736 [TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591 [TBL] [Abstract][Full Text] [Related]
3. Effect of exogenous tumor necrosis factor alpha, interleukin 6 and interferons on vesicular stomatitis virus replication in human placenta and amniotic membrane organ cultures. Paradowska E; Blach-Olszewska Z; Gierlińska M; Woytoń J Arch Immunol Ther Exp (Warsz); 1996; 44(1):57-62. PubMed ID: 8874771 [TBL] [Abstract][Full Text] [Related]
4. [Use of Getah virus for antiviral assay of human interferon]. Ogiso S; Shirai J; Tuchiya Y; Honda E Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019 [TBL] [Abstract][Full Text] [Related]
5. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells. Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598 [TBL] [Abstract][Full Text] [Related]
6. A bioassay for interferon type I based on inhibition of Sendai virus growth. Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385 [TBL] [Abstract][Full Text] [Related]
7. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. Berger Rentsch M; Zimmer G PLoS One; 2011; 6(10):e25858. PubMed ID: 21998709 [TBL] [Abstract][Full Text] [Related]
8. Post HCV Infection Due to MX Gene Stimulation Produced Post Treatment with Imported and Locally Produced Egyptian Biosimilar IFN. Mohamed SH; Mahmoud NF; Mohamed AF; Kotb NS Asian Pac J Cancer Prev; 2015; 16(14):5635-41. PubMed ID: 26320428 [TBL] [Abstract][Full Text] [Related]
9. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β. Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076 [TBL] [Abstract][Full Text] [Related]
10. [Expression of bovine interferon gamma in recombinant baculovirus and determination of its antiviral activity]. Qin LT; Wang XJ; Hu S; Liu SD; Bu ZG Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):503-7. PubMed ID: 17672314 [TBL] [Abstract][Full Text] [Related]
11. A simple and efficient microassay method for titration of interferon. Ishitsuka H; Nomura Y; Takano K Microbiol Immunol; 1977 Oct; 21(10):583-91. PubMed ID: 201822 [TBL] [Abstract][Full Text] [Related]
12. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. Wollmann G; Robek MD; van den Pol AN J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Carter CC; Gorbacheva VY; Vestal DJ Arch Virol; 2005 Jun; 150(6):1213-20. PubMed ID: 15717119 [TBL] [Abstract][Full Text] [Related]
14. Murine GFP-Mx1 forms nuclear condensates and associates with cytoplasmic intermediate filaments: Novel antiviral activity against VSV. Sehgal PB; Yuan H; Scott MF; Deng Y; Liang FX; Mackiewicz A J Biol Chem; 2020 Dec; 295(52):18023-18035. PubMed ID: 33077519 [TBL] [Abstract][Full Text] [Related]
15. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells. Maheshwari RK; Friedman RM J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998 [TBL] [Abstract][Full Text] [Related]
16. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins. Wallach D J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250 [TBL] [Abstract][Full Text] [Related]
17. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C. Cembrzyńska-Nowak M Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831 [TBL] [Abstract][Full Text] [Related]
18. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Dalton KP; Rose JK Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797 [TBL] [Abstract][Full Text] [Related]
19. [Expression of porcine interferon-gamma and its safe antiviral assay]. He F; Sun Y; Ge J; Li M; Chang T; Bu Z; Qiu H Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):439-47. PubMed ID: 20575430 [TBL] [Abstract][Full Text] [Related]